Companies / Thailand
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Government Boosts Generic Oseltamivir Output
August 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Thailand is planning to extend its production of oseltamivir, the generic version of Swiss drugmaker Roche's anti-flu medicine Tamiflu. The state run Government Pharmaceutical Organisation (GPO) will have the capacity to produce 400,000 capsules of the drug per day, after the upgrading. Presently, the firm manufactures the drug using bulk materials imported from India, although in the long term it hopes to develop its own independent production